Dr. Fei Sun

Dr. Fei Sun

Senior scientist

Email

fsun@hbku.edu.qa

Office location

N-1459A

Dr. Fei Sun

Senior scientist

Educational Qualifications

PhD in Immunology

BSc in Medicine

Entity

Qatar Biomedical Research Institute

Division

Diabetes Research Center

Biography

Dr. Fei Sun earned his BSc degree in Medicine from Xiamen University, China, and his PhD degree in Immunology from Huazhong University of Science and Technology (HUST), China. He received post-doctoral training in Endocrinology at Tongji Hospital, Tongji Medical College, HUST. His research focuses on immune-metabolic crosstalk in obesity, obesity-associated metabolic disorders, and the pathogenesis of type 1 (T1D) and type 2 (T2D) diabetes. He hosted both translational and basic science research projects, and published his work in renowned journals such as Cell Metabolism, Journal of Clinical Investigation, and Molecular Therapy.

PhD in Immunology

Huazhong University of Science and Technology, China

2020

BSc in Medicine

Xiamen University, China

2014

  • Obesity and obesity-associated metabolic disorders
  • Type 1 diabetes pathogenesis
  • Diabetic complications
  • Immunometabolism

Senior Scientist

Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University

2026 - Present

Assistant Professor

Tongji Hospital, Huazhong University of Science and Technology, China

2024 - 2026

Research Fellow

Tongji Hospital, Huazhong University of Science and Technology, China

2021 - 2024

Zhong, Z., Liang, G., Yu, H., Li, J., Wang, R., Ma, X., Zhou, Z., Zhao, Y., Sun, F., & Sun, X. (2025). SUMOylation is a Translatable Target in Hypoxic MNPs Regulating Retinal Vasculopathy. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12(31), e03505.

Luo, J. H., Wang, F. X., Zhao, J. W., Yang, C. L., Rong, S. J., Lu, W. Y., Chen, Q. J., Zhou, Q., Xiao, J., Wang, Y. N., Luo, X., Li, Y., Song, D. N., Chen, C., Zhang, C. L., Chen, S. H., Yang, P., Xiong, F., Yu, Q. L., Zhang, S., … Wang, C. Y. (2024). PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders. Cell metabolism, 36(10), 2262–2280.e5. 

Yang, C. L., Wang, F. X., Luo, J. H., Rong, S. J., Lu, W. Y., Chen, Q. J., Xiao, J., Wang, T., Song, D. N., Liu, J., Mo, Q., Li, S., Chen, Y., Wang, Y. N., Liu, Y. J., Yan, T., Gu, W. K., Zhang, S., Xiong, F., Yu, Q. L., … Wang, C. Y. (2024). PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2. Molecular therapy : the journal of the American Society of Gene Therapy, 32(8), 2778–2797. 

Sun, F., Yang, C. L., Wang, F. X., Rong, S. J., Luo, J. H., Lu, W. Y., Yue, T. T., Wang, C. Y., & Liu, S. W. (2023). Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes. Cell & bioscience, 13(1), 156. 

Sun, F., Wang, F. X., Zhu, H., Yue, T. T., Yang, C. L., Luo, J. H., Luo, X., Zhou, H. F., Rong, S. J., Lu, W. Y., Zhou, Q., Yang, P., Xiong, F., Liu, Y. J., Yan, T., Liao, Y. F., Zhang, S., & Wang, C. Y. (2022). SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis. Cell death & disease, 13(2), 181. 

Complete Publication Listing(s): ORCID

  • 2014: Outstanding Graduate Award, Xiamen University
  • 2022: F1000 Travel Grant for Immunology, Faculty Opinions
  • 2023: Outstanding Innovative Postdoctoral Fellow, Hubei Provincial Government
  • 2024: Hubei Natural Science Award, Hubei Provincial Government